Abstract
Objectives To determine the prognostic value of Gd-EOB-DTPA MRI findings of liver metastasis from breast cancer. Methods 29 metastatic lesions from 12 breast cancer patients who received chemotherapy were retrospectively reviewed. We evaluated hepatobiliary phase of the lesions and classified them as a “target” or “non-target” appearance. The relationship of appearance or SI ratio with tumor response was analyzed. Results A non-target appearance was more frequent in disease control group than in non-control group [14/18 (77.8%) vs. 4/18 (22.2%)], and it was associated with a better response [p = 0.048]. Conclusion HBP analysis may be useful to predict the response to chemotherapy and survival.
Original language | English |
---|---|
Pages (from-to) | 127-131 |
Number of pages | 5 |
Journal | Clinical Imaging |
Volume | 43 |
DOIs | |
Publication status | Published - 2017 May 1 |
Externally published | Yes |
Keywords
- Breast cancer liver metastases
- Chemotherapy response
- Gadoxetic acid
- Hepatobiliary phase (HBP)
- MRI
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging